An AI product strategy is the portfolio-level decision about where AI investment can build a durable advantage in a product, and where it's a commodity everyone can buy the same way, made before any single feature or rollout gets funded. As of September 2026, after 15 years leading product and engineering teams, including through eight acquisitions inside a regulated clinical research organization, I keep seeing companies confuse this with a features list: a slide of things AI could do, ranked by how impressive the demo looks. That's not a strategy. A strategy says which parts of the roadmap AI is even allowed to touch this year, and why those parts and not the others, before anyone opens a chat window to check what's possible.
What is AI product strategy?
AI product strategy is the decision about which parts of a product roadmap deserve AI investment, and which don't, made at the portfolio level before any single feature is scoped. It answers where AI can build a durable advantage versus where it's a commodity anyone with API access can copy by next quarter.
I've sat through this pitch a dozen ways over eight acquisitions and as many product reviews: a target company or an internal team has a list of things AI could plausibly help with, and the strategy conversation stops at ranking the list. What's usually missing is the harder question underneath: which of these would still matter if a competitor stood up the same model in a weekend? A roadmap has room for both kinds of ideas. Conflating them is how a company spends its differentiation budget on something anyone can buy off the shelf, and calls the receipt a strategy.
How is AI product strategy different from an AI adoption framework?
An AI product strategy decides whether AI belongs on the roadmap at all and where. An AI adoption framework decides how a tool that's already been chosen moves from a bounded pilot to full rollout inside one team. Strategy picks the arena. Adoption runs the sequence once you're standing in it.
I wrote the five-stage version of that sequence, readiness, a bounded pilot, workflow fit, evidence, scale, in an AI adoption framework. That framework assumes the arena question is already settled: someone has decided this team, this workflow, is worth testing a tool against. Strategy is the layer above it. It's where a company decides which two or three workflows across the whole roadmap are even candidates for that framework this year, and which aren't, no matter how enthusiastic the internal pitch is. Skip straight to adoption without a strategy first, and a company ends up running five bounded pilots in five unrelated corners of the business, none of them chosen because they mattered more than the ones that never got tried.
How is AI product strategy different from AI product discovery?
AI product discovery tests one feature-level decision: whether a real user pain, real data, an acceptable risk, and workflow fit line up for a specific idea. AI product strategy decides which decisions are even worth putting through that test, and in what order, based on where the company already holds an advantage a competitor can't copy quickly.
I laid out the four discovery checks, pain, data, risk, workflow fit, in AI product discovery. Every one of those checks assumes you already know which feature you're testing. Strategy is what decides that queue. Without it, discovery turns into first-come-first-served: whoever pitches loudest gets tested first, and the team spends a quarter validating something that was never going to be defensible even if every check passed. Strategy doesn't replace discovery. It decides which ideas earn a discovery cycle before a model ever gets picked.
Where does AI actually create a durable advantage in a product?
A durable advantage shows up where a company holds data, a workflow, or a cost of being wrong that a competitor can't replicate by calling the same API: proprietary usage data that compounds over time, a workflow embedded deep enough that removing it breaks real work, or hard-won practice managing a failure mode a newcomer hasn't seen yet. Generic model capability, alone, is not an advantage.
This is close to what investors call an economic moat, the term Warren Buffett made famous for judging which businesses can defend their profits once everyone can see how they're made. The same test applies to a single AI feature, at a smaller scale. Here's the version I actually walk a roadmap through:
| Signal | Commodity capability | Defensible position |
|---|---|---|
| Data | Public or generic training data; a competitor's model performs about the same | Proprietary usage data that compounds with every real customer interaction |
| Workflow depth | A bolt-on feature, easy to switch off or replace | Embedded deep enough that removing it breaks a real, daily workflow |
| Cost of a wrong answer | Low; a bad output is quietly ignored or redone | High, and already understood, from a company with years of practice managing that exact failure |
| Speed to copy | A competitor ships something similar within a quarter | Requires years of the same data or workflow position to replicate, not just the same model |
I ran this test constantly across acquisitions, usually against the target's own AI slide: which of these four rows was actually true for the feature in front of me, versus which ones the pitch assumed were true because the demo was impressive. That's an inference I've drawn from watching the same pattern repeat across a specific, regulated industry, not a law that holds everywhere AI touches a product. But inside it, a capability that scores commodity on all four rows isn't a bad idea. It's just not a strategy. It's a feature, and it should be scoped, built, and shipped as one, quickly, because a slow build of something anyone can copy is the worst use of a differentiation budget.
How do you sequence an AI product strategy across a roadmap?
Sequence it top-down: strategy picks the two or three workflows on the roadmap that score highest for durable advantage, discovery tests the specific decision inside each one, and an adoption framework rolls out whichever tool passes that test. Running the steps in the other order is how companies adopt tools for problems discovery never validated, in workflows strategy never chose.
None of this makes the individual pitches wrong. A team asking to prototype a support-ticket summarizer, a smarter search feature, or a drafting assistant is usually right that the underlying capability works. The question a strategy is supposed to answer, before any of those pitches gets a discovery cycle, is why this one and not the four others sitting in the same backlog. In my experience the honest answer is almost always about data, workflow depth, or the cost of getting it wrong, and only rarely about which idea got the best applause in the room where it was pitched.